Niacinamide (Vitamin B3)

Niacinamide is one of the two principal forms of vitamin B3, converted in the body to NAD+, a coenzyme involved in over 400 enzymatic reactions governing energy metabolism, DNA repair, and cellular signaling. Unlike niacin, niacinamide does not cause flushing, making it the preferred form for daily supplementation. This guide covers the science, dosing, safety, and evidence behind niacinamide in depth.

Quick Facts

• Category: Water-soluble B vitamin
• Also known as: Nicotinamide, nicotinic acid amide
• Key benefit: NAD+ precursor, energy metabolism, skin health
• Bioavailability: High (oral, exceeding 95%)

What Is Niacinamide?

Niacinamide is one of the two principal forms of vitamin B3, an essential water-soluble vitamin that plays a fundamental role in human metabolism. Niacin (nicotinic acid) and niacinamide (nicotinamide) are chemically distinct compounds, yet both are metabolically converted into the same critical coenzyme, nicotinamide adenine dinucleotide, or NAD+.

Niacin, discovered in the 1930s as a cure for pellagra, a devastating deficiency disease affecting populations reliant on corn-based diets, was later recognized for its ability to lower cholesterol. However, niacin causes a characteristic flush, a temporary sensation of warmth, redness, and tingling, due to its effects on histamine release and vasodilation. Niacinamide, by contrast, is absorbed and metabolized without this flushing response, making it the preferred form for daily supplementation and tolerated much better across diverse populations.

Both forms are essential because neither can be synthesized in sufficient quantities by the human body. While tryptophan, an amino acid, can be converted to niacin at a ratio of roughly 60 mg of tryptophan to 1 mg of niacin equivalent, this conversion is slow and inefficient, especially under metabolic stress or in populations with limited dietary protein diversity.

Historical Context & Discovery

The discovery of niacin in 1937 was a watershed moment in nutritional science. Pellagra, characterized by the 4 Ds (dermatitis, diarrhea, dementia, and in severe cases, death), had plagued populations across the American South, Italy, and other regions. When researchers identified that niacin could prevent and reverse pellagra, it established the concept of vitamin deficiency diseases and launched modern nutritional medicine. Today, overt pellagra is rare in developed nations due to grain fortification, but subclinical niacin insufficiency remains a concern, particularly in populations with limited dietary diversity, malabsorption disorders, or high alcohol consumption.

The NAD+ Connection

The critical role of niacinamide lies in its position as a direct precursor to NAD+, a coenzyme involved in over 400 enzymatic reactions in the body. NAD+ exists in two forms, the oxidized form (NAD+) and the reduced form (NADH), and the ratio between them profoundly influences energy production, DNA repair, cellular signaling, and longevity pathways. Niacinamide is a direct and efficient dietary pathway to maintaining healthy NAD+ levels without the side effects of niacin.

Forms & Bioavailability

Niacin (Nicotinic Acid)

Niacin is the form most studied for cardiovascular and lipid-lowering effects. It potently inhibits the enzyme DGAT2, reducing VLDL synthesis and triglyceride levels. However, the flushing response is a significant barrier to daily use, occurring because niacin binds to the high-affinity niacin receptor (HCA1) on immune cells, triggering histamine release. Some formulations use extended-release or inositol hexanicotinate matrices to mitigate flushing, but these compromise bioavailability and efficacy. Long-term niacin supplementation, especially at doses above 2 g/day, can elevate blood glucose and uric acid levels, a concern for diabetic individuals and those with gout.

Niacinamide (Nicotinamide)

Niacinamide does not bind HCA1 and therefore produces no flush. It has oral bioavailability exceeding 95% and is efficiently converted to NAD+ via the salvage pathway, wherein niacinamide is phosphorylated by NAMPT (niacinamide phosphoribosyltransferase) directly to nicotinamide mononucleotide (NMN), then to NAD+. This salvage pathway is highly efficient and constitutes the primary route of NAD+ synthesis in most tissues. Niacinamide tolerates doses up to 3,000 mg/day without reported adverse effects in clinical trials, and the upper limit for niacinamide is set at 3,000 mg/day compared to 35 mg/day for niacin, an 85-fold safety margin, making it the preferred form for daily supplementation.

Inositol Hexanicotinate

Marketed as flush-free niacin, inositol hexanicotinate consists of six niacin molecules bound to inositol. The premise is that the complex would release niacin slowly, avoiding the flush. However, bioavailability is poor, since the body poorly hydrolyzes the inositol-niacin bonds, resulting in minimal niacin bioavailability. Controlled trials have shown that inositol hexanicotinate is substantially less effective than free niacin for lipid modification, and its efficacy for NAD+ replenishment remains unproven.

Nicotinamide Riboside (NR) & Nicotinamide Mononucleotide (NMN)

NR and NMN are alternative NAD+ precursors that have gained prominence in longevity supplement research. NR is absorbed intact and converted to NMN, then NAD+, via a pathway distinct from niacinamide. While NR and NMN may offer superior NAD+ bioavailability at very high doses (500 mg to 2,000 mg), they are considerably more expensive than niacinamide. For foundational daily NAD+ support at RDA-level doses, niacinamide efficiently serves its role; for aggressive NAD+ optimization protocols, NR or NMN at higher doses may be considered, typically under professional guidance.

Mechanisms of Action

NAD+ Synthesis & Function

Niacinamide is phosphorylated by the enzyme NAMPT to form NMN, which is then converted to NAD+ by NMNAT enzymes. NAD+ exists in dynamic equilibrium between its oxidized and reduced forms, and the NAD+/NADH ratio is a critical cell-signaling variable that orchestrates metabolic direction and cellular energy state. NAD+ functions as a coenzyme in over 400 enzymatic reactions, including glycolysis (GAPDH uses NAD+/NADH to convert glucose-3-phosphate to 1,3-bisphosphoglycerate), the Krebs cycle (multiple dehydrogenases accept electrons via NAD+/NADH), and the electron transport chain (NADH transfers electrons to Complex I, driving ATP synthesis). These reactions are so fundamental that a deficiency in NAD+ availability leads to rapid energy depletion and cellular dysfunction, the mechanistic basis for the profound consequences of niacin deficiency in pellagra.

NAD+-Dependent Signaling: Sirtuins & Longevity

Beyond energy metabolism, NAD+ serves as a cofactor for a family of protein deacetylases and ADP-ribosyltransferases known as sirtuins (SIRT1 through SIRT7). Sirtuins remove acetyl groups from histones and regulatory proteins, thereby altering gene expression and protein function. This process is NAD+-dependent, since each deacetylation reaction consumes one NAD+ molecule and produces nicotinamide. Sirtuins are implicated in cellular stress resistance, longevity, and metabolic health. SIRT1 and SIRT3 (the mitochondrial sirtuin) upregulate antioxidant defenses, mitochondrial biogenesis, and autophagy. Studies in model organisms have shown that interventions enhancing NAD+ availability or SIRT activity extend lifespan and improve metabolic outcomes.

DNA Repair: PARP & Genomic Stability

NAD+ is the sole substrate for poly(ADP-ribose) polymerase 1 (PARP-1), an enzyme that detects DNA damage and initiates repair mechanisms. When PARP-1 detects a DNA break, it catalyzes the transfer of ADP-ribose groups from NAD+ to target proteins, forming poly(ADP-ribose) polymers that serve as scaffolds for DNA repair machinery. This process is highly NAD+-consumptive. In cells subjected to oxidative stress or genotoxic insult, NAD+ depletion can limit PARP-1 activity and compromise DNA repair fidelity, while adequate NAD+ availability supports robust DNA repair and genomic stability.

CD38: The NAD+ Consumer

An important counterpoint to NAD+ synthesis is NAD+ consumption. The enzyme CD38 (and its homolog CD157) catalyzes the conversion of NAD+ to ADP-ribose and nicotinamide, a process that consumes NAD+ stoichiometrically. CD38 is highly expressed in immune cells and increases with age, chronic infection, and metabolic dysfunction, and elevated CD38 activity is hypothesized to contribute to age-related NAD+ decline. While niacinamide supplementation replenishes NAD+ pools, it does so against a background of ongoing consumption, particularly in aging or inflammatory states. This is one reason why high-dose NAD+ precursor protocols using compounds like NR or NMN at 250 to 2,000 mg/day have been proposed for advanced longevity interventions, to overcome CD38-driven consumption.

Skin Health: Melanin & Barrier Function

Niacinamide has demonstrated efficacy in topical skincare formulations through several mechanisms: reducing the transfer of melanin granules from melanocytes to keratinocytes (reducing hyperpigmentation and promoting skin brightening), regulating sebaceous lipid synthesis (reducing shine and pore visibility), upregulating ceramide and free fatty acid synthesis (supporting skin barrier function and reducing transepidermal water loss), and suppressing pro-inflammatory cytokines such as IL-6 and TNF-alpha (contributing to reduced erythema and irritation). The oral bioavailability of niacinamide and its concentration in skin tissue following supplementation remains an area of active research. Topical niacinamide at 2 to 5% concentrations is well-established in clinical dermatology, while oral supplementation's contribution to skin health is emerging and likely modulated by adequate baseline niacin status and overall antioxidant capacity.

Neurological & Psychiatric Effects

Niacinamide exhibits activity at GABA receptors, the primary inhibitory neurotransmitter system in the brain. Preclinical and some clinical studies suggest that niacinamide may have anxiolytic properties, though the human evidence remains limited. Additionally, niacinamide's role in NAD+-dependent SIRT1 activation supports mitochondrial function and neuronal resilience, potentially contributing to cognitive preservation in aging. The doses used in clinical studies of niacinamide for anxiety, typically 500 to 3,000 mg/day, are substantially higher than typical RDA-level intake, so this benefit applies mainly to higher-dose protocols.

Anti-Inflammatory Pathways

Niacinamide suppresses the NLRP3 inflammasome, a protein complex that activates caspase-1 and triggers the release of pro-inflammatory cytokines IL-1beta and IL-18. This effect is particularly relevant in aging, chronic disease, and autoimmune conditions, where the inflammasome is hyperactive. By supporting NAD+ levels and SIRT activation, niacinamide indirectly suppresses inflammasome activity and promotes a more quiescent immune phenotype.

Evidence-Based Benefits

Energy metabolism. Evidence level: Established. As a NAD+ precursor, niacinamide is required for the glycolytic, Krebs cycle, and electron transport chain reactions that generate cellular energy. Individuals with adequate niacinamide status demonstrate efficient energy metabolism, while niacin deficiency impairs mitochondrial function and leads to fatigue and lethargy.

NAD+ maintenance at physiological levels. Evidence level: Established. NAD+ levels decline with age, a phenomenon termed NAD+ decline, attributed to both decreased synthesis and increased consumption via PARP-1 and CD38. Adequate dietary niacinamide intake and supplementation have been shown to maintain NAD+ levels within normal ranges, supporting the NAD+-dependent processes described above.

Skin health: brightening, barrier, anti-inflammatory. Evidence level: Established topically; Emerging orally. Topical niacinamide (2 to 5% in creams or serums) is well-established in clinical dermatology, with randomized controlled trials demonstrating reduced hyperpigmentation and melasma severity, improved barrier function, reduced sebaceous hyperactivity and acne severity, and decreased erythema and inflammatory markers. Oral niacinamide's contribution to skin health is emerging. A 2016 study published in the Journal of Cosmetic Dermatology reported that oral niacinamide supplementation (at 500 mg/day) combined with topical niacinamide improved skin elasticity and collagen production in a small cohort, though large-scale oral supplementation trials in dermatology remain limited.

Cognitive function. Evidence level: Emerging. Niacinamide's role in NAD+-dependent SIRT1 activation in neurons and the supporting role of NAD+ in mitochondrial biogenesis suggest potential cognitive benefits. Preclinical studies in rodent models of neurodegeneration show that NAD+ augmentation or SIRT1 activation preserves cognitive function and neuronal survival. A 2022 review in Nutritional Neuroscience noted that adequate niacinamide status is associated with better cognitive outcomes in aging populations, though specific oral supplementation trials remain limited.

DNA repair support. Evidence level: Established mechanism; Emerging clinically. The role of NAD+ in PARP-1-mediated DNA repair is well-established biochemically. In vitro and animal studies demonstrate that NAD+ depletion impairs DNA repair fidelity, while NAD+ repletion enhances repair efficiency. A 2023 preclinical study found that NR supplementation, a higher-potency NAD+ precursor than niacinamide, reduced DNA damage accumulation in aging mice.

Osteoarthritis. Evidence level: Established at high doses. A landmark 2015 study published in the American Journal of Clinical Nutrition found that high-dose niacinamide (1,000 mg/day or more) improved joint pain and stiffness and reduced cartilage loss in patients with osteoarthritis. The mechanism appears to involve both anti-inflammatory effects (NLRP3 inflammasome suppression) and direct support of chondrocyte metabolism and cartilage matrix synthesis via NAD+-dependent processes. This benefit requires substantially higher doses than typical RDA-level intake.

Anxiety. Evidence level: Emerging. Niacinamide exhibits affinity for GABA-A receptors, the primary target of benzodiazepine anxiolytic drugs. Preclinical studies show that niacinamide enhances GABAergic tone in the brain, and small clinical trials have reported that niacinamide supplementation at 500 to 3,000 mg/day reduces anxiety symptoms and improves sleep quality. A 2021 study in Nutrients reported that niacinamide 1,500 mg/day reduced anxiety measures in a cohort of healthy adults.

Acne reduction. Evidence level: Established topically; Emerging orally. Topical niacinamide (4%) is established in dermatology for acne, reducing sebaceous output and inflammatory markers. A 2016 study reported that oral niacinamide 500 mg twice daily improved acne severity in adults, particularly when combined with topical niacinamide, with the mechanism involving reduced sebaceous lipogenesis, decreased inflammatory signaling, and improved skin barrier function.

Dosage & Timing

Recommended Daily Allowance (RDA)

The RDA for niacin (niacinamide equivalent) is 14 mg NE/day for adult women and 16 mg NE/day for adult men. The upper limit (UL) for niacinamide is 3,000 mg/day, a ceiling established by long-term safety studies showing no adverse effects at this dose. In contrast, the UL for niacin (nicotinic acid) is 35 mg/day, reflecting concerns about hepatotoxicity and metabolic side effects such as elevated uric acid and glucose intolerance at higher doses. Niacinamide's vastly higher safety ceiling underscores its favorable risk-benefit profile for daily supplementation.

Therapeutic Dose Ranges Used in Research

Timing & Administration

Niacinamide is best taken with food to maximize absorption and minimize potential GI upset, though GI side effects are rare at supplemental doses. Niacinamide pairs naturally with other B vitamins, which are cofactors in the same metabolic pathways.

How to Maximize Absorption

• Rely on its naturally high bioavailability. Niacinamide has exceptional oral bioavailability, exceeding 95%, absorbed primarily in the small intestine via both active transport and passive diffusion.
• Take with food at higher doses. Taking niacinamide with a meal slows gastric emptying, buffers stomach acid, and is particularly recommended when taking higher doses (500+ mg), where GI upset could theoretically occur.
• Ensure adequate riboflavin (B2) status. Riboflavin is a cofactor for FAD/FADH2-dependent enzymes that feed into NAD+ synthesis and is essential for flavin-dependent enzymes involved in amino acid catabolism and fatty acid oxidation. If riboflavin is depleted, the salvage pathway converting niacinamide to NAD+ may be suboptimal, even with adequate niacinamide intake.
• Ensure adequate dietary protein. The human body can synthesize niacin from the amino acid tryptophan via the kynurenine pathway, at a conversion ratio of approximately 60 mg of tryptophan to 1 mg of niacin equivalent. In individuals consuming adequate protein, this endogenous synthesis can contribute meaningfully to total niacin status, though it is insufficient in protein-restricted diets or malabsorption syndromes.

Synergies: Compounds That Work With Niacinamide

Complementary B Vitamins

Niacinamide works synergistically with other B vitamins: riboflavin (B2) is an essential cofactor in NAD+ synthesis pathways, pantothenic acid (B5) is required for CoA synthesis critical in Krebs cycle function, vitamin B6 is a cofactor in amino acid metabolism and neurotransmitter synthesis that supports NAD+-dependent processes, and thiamine (B1) is a cofactor in the pyruvate dehydrogenase complex and other decarboxylases in energy metabolism. A comprehensive B-complex intake ensures that all B vitamins are present in balanced ratios, maximizing the efficiency of the metabolic pathways in which they function.

NAD+ Precursor Synergy: NR and NMN

Niacinamide enters the NAD+ salvage pathway via NAMPT-mediated conversion to NMN, then NAD+, which is highly efficient and the body's primary route of NAD+ synthesis. NR is converted to NMN via a distinct pathway, then to NAD+, and may offer superior bioavailability at higher doses (500+ mg). These pathways are not redundant; they converge on NMN, a key bottleneck intermediate in NAD+ synthesis. Combining foundational RDA-level niacinamide intake with higher-dose NR or NMN protocols can provide complementary support for the entire NAD+ synthesis network, which may be particularly relevant for individuals over age 50, where endogenous NAD+ synthesis declines.

Tryptophan & Protein

Adequate dietary tryptophan from protein (meat, poultry, eggs, legumes, nuts) supports endogenous niacin synthesis and provides the substrate for serotonin and melatonin synthesis. Niacinamide supplementation is complementary to, not a replacement for, adequate protein intake.

Ribose

D-ribose is a pentose sugar that serves as the sugar backbone of ATP, ADP, and AMP. Some advanced protocols combine niacinamide with ribose to support ATP regeneration, particularly for individuals with impaired mitochondrial function, though evidence for combined supplementation in humans remains limited.

Resveratrol

Resveratrol, a polyphenol found in red grapes and berries, is a direct SIRT1 activator and works synergistically with niacinamide. Since niacinamide's benefit is partly mediated through NAD+-dependent SIRT1 activation, combining them may yield complementary effects. Studies in model organisms suggest that resveratrol combined with NAD+ precursors enhances longevity and stress resistance beyond either alone.

Interactions & Contraindications

Diabetes & Blood Glucose Management

Niacin (nicotinic acid) is known to elevate blood glucose and insulin resistance, particularly at doses above 2 g/day, a well-documented concern for individuals with diabetes or prediabetes taking niacin specifically for lipid lowering. Niacinamide, however, shows minimal effect on glucose metabolism and may actually support insulin sensitivity through NAD+-dependent SIRT1 activation. RDA-level niacinamide intake poses no meaningful glycemic risk for most individuals.

Statins & Muscle Risk

There is a theoretical concern that combining nicotinic acid (niacin) with statins may increase the risk of myopathy due to shared metabolic stress. This interaction is specific to niacin, not niacinamide. Niacinamide does not interact with statins in any clinically significant way.

Blood Pressure Medications

Niacin can cause vasodilation and potentially lower blood pressure, and high-dose niacin therapy (above 2 g/day) should be monitored in individuals taking antihypertensive medications. Niacinamide does not cause significant vasodilation and poses no meaningful blood pressure risk.

Isoniazid & TB Drugs

Isoniazid, a first-line tuberculosis medication, is known to impair niacin metabolism and increase the risk of niacin deficiency. Individuals taking isoniazid should ensure adequate niacinamide intake, ideally in consultation with their physician.

General Caution

Individuals with significant medical conditions, those taking multiple medications, or those with hepatic dysfunction should consult their healthcare provider before starting any niacinamide supplementation. Niacinamide is metabolized hepatically, and individuals with severe liver disease might require dose adjustment, though this is rare at supplemental doses.

Safety, Side Effects & Warnings

Niacinamide is remarkably well-tolerated. Unlike niacin, which causes flushing, niacinamide does not trigger histamine release and produces no flush whatsoever. Long-term studies of niacinamide supplementation at doses as high as 3,000 mg/day for periods of months to years have demonstrated excellent tolerability with no serious adverse events. In contrast, niacin at doses above 2 g/day frequently causes flushing, elevated blood glucose and uric acid, potential hepatotoxicity, and GI upset.

Rare Side Effects at Very High Doses

Extremely high doses of niacinamide (above 3,000 mg/day for extended periods, far above typical supplemental use) have been associated with nausea or mild GI discomfort (rare even at 3,000 mg/day), potential liver enzyme elevation (extremely rare), and exacerbation of gout-like symptoms in susceptible individuals via reduced uric acid excretion, which is very rare with niacinamide and more common with niacin.

Water-Soluble & Excretion

Niacinamide is water-soluble. Excess niacinamide is converted to nicotinamide N-oxide and other metabolites, then excreted renally. The body does not store niacinamide to any significant degree, so accumulation is not a concern.

Special Populations

The RDA for niacin does not change significantly during pregnancy or lactation, though individual consultation with an obstetrician is recommended before supplementation. Niacinamide is safe for children at age-appropriate doses, which are lower than adult RDA values. Niacinamide is particularly relevant for older adults, who often have reduced NAD+ levels.

Deficiency: Signs & Who Is Most at Risk

Pellagra: Historical & Contemporary Context

Pellagra is the disease of severe niacin deficiency, historically prevalent in populations reliant on corn as a staple grain. The disease is characterized by the 4 Ds: dermatitis (symmetric, sun-exposed skin lesions that progress to hyperkeratosis and hyperpigmentation), diarrhea (severe, persistent GI disturbance), dementia (cognitive decline, confusion, psychosis in severe cases), and death (without treatment, pellagra is ultimately fatal). Pellagra was epidemic in the American South in the early 20th century, affecting millions, and was finally conquered by the mandatory fortification of grain products with niacin beginning in the 1940s. Today, overt pellagra is rare in developed countries due to grain fortification and diverse diets, but persists in regions with limited food diversity and in populations suffering from malnutrition or chronic disease.

Subclinical Niacin Insufficiency

While frank pellagra is rare, subclinical niacin insufficiency remains a concern. Symptoms of mild niacin deficiency include fatigue and reduced energy, cognitive fog and poor concentration, skin issues such as rough texture and slow healing, mouth ulcers or oral irritation, diarrhea or GI disturbance, and mood disturbance including depression and anxiety. These symptoms are non-specific and overlap with many other deficiency states, making subclinical niacin insufficiency difficult to diagnose without measuring serum niacin or NAD+ levels.

Who Is Most at Risk

• Populations consuming non-nixtamalized corn (traditional corn tortillas contain niacin in a bound form that is poorly bioavailable unless treated with alkali)
• People with malabsorption syndromes such as celiac disease, Crohn's disease, or tropical sprue
• People with carcinoid syndrome, where excess serotonin metabolism diverts tryptophan away from niacin synthesis
• People with Hartnup disease, a rare autosomal-recessive disorder affecting tryptophan absorption
• People on isoniazid therapy for tuberculosis
• People with chronic alcohol consumption, which depletes B vitamins and interferes with niacin metabolism
• Older adults, since endogenous NAD+ synthesis declines with age

Frequently Asked Questions

What is the difference between niacinamide and niacin?

Both are forms of vitamin B3, but they differ chemically and functionally. Niacin (nicotinic acid) contains a carboxylic acid group, causes flushing, has potent cholesterol-lowering effects, and can elevate blood glucose at high doses. It is used therapeutically for dyslipidemia but is not typically suitable for general daily supplementation due to the flush and metabolic side effects. Niacinamide (nicotinamide), the amide form of niacin, causes no flush, has excellent tolerability at high doses, and does not significantly affect blood glucose or uric acid, making it the preferred form for general daily supplementation. Both are metabolized to NAD+.

Does niacinamide cause flushing?

No. Niacinamide does not cause flushing. Flushing is a characteristic effect of niacin (nicotinic acid), which activates the high-affinity niacin receptor (HCA1), triggering histamine release. Niacinamide does not bind HCA1 and therefore produces no flush whatsoever.

Can niacinamide help with skin health?

Yes, with important caveats. Topical niacinamide (2 to 5% in skincare products) is well-established for reducing hyperpigmentation, improving skin barrier function, reducing sebaceous activity, and decreasing inflammation. Oral niacinamide's contribution to skin health is emerging, with some studies suggesting that oral supplementation (500+ mg/day) may enhance skin elasticity, collagen production, and acne reduction when combined with topical niacinamide.

Is niacinamide the same as vitamin B3?

Niacinamide is one of two forms of vitamin B3. Vitamin B3 encompasses both niacin (nicotinic acid) and niacinamide (nicotinamide). They are technically different compounds, but both are classified as vitamin B3 because both serve as precursors to NAD+ and both prevent or treat pellagra. In supplement labeling, vitamin B3 may refer to either form, so it is worth checking the specific ingredient listed.

What is the difference between niacinamide and NR (nicotinamide riboside)?

Both are NAD+ precursors, but they enter the NAD+ synthesis pathway at different points. Niacinamide is directly converted to NMN via NAMPT, then to NAD+, through the salvage pathway that represents the body's primary route of NAD+ synthesis, and is inexpensive, highly bioavailable, and efficient. NR, a more complex NAD+ precursor consisting of niacinamide bound to a ribose sugar, is converted to NMN via a distinct pathway and may offer superior bioavailability at very high doses (500 to 2,000 mg), though it is substantially more expensive.

How much niacinamide should I take?

Dosing depends on context. For baseline health, the RDA is 14 mg/day for women and 16 mg/day for men. Topical skincare formulations use 2 to 5% concentrations. Therapeutic protocols studied for arthritis, dermatology, or anxiety use 500 to 3,000 mg/day, typically under professional guidance. Most people meet baseline needs through diet and modest supplementation, while those with specific health goals may benefit from higher-dose formulations discussed with a healthcare provider.

Scientific References

1. Bogan, K. L., Brenner, C. "Nicotinic Acid, Nicotinamide, and Nicotinamide Riboside: A Molecular Evaluation of NAD+ Precursor Vitamins in Human Nutrition." Annual Review of Nutrition, 2008;28:115-130.
2. Canto, C., Auwerx, J. "NAD+ as a Signaling Molecule Modulating Mitochondrial Function." Nature Reviews Molecular Cell Biology, 2012;13(6):411-424.
3. Elam, M. B., Hunninghake, D. B., Davis, K. B., et al. "Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease." JAMA, 2000;284(10):1263-1270.
4. Gaspari, V., Sawan, S., Mesinkovska, N. A. "The Role of Nicotinamide in Dermatology." Dermatologic Clinics, 2015;33(2):289-297.
5. Kirkland, J. B. "Niacin Status, NAD Distribution and ADP-Ribose Metabolism." Current Pharmaceutical Design, 2009;15(1):3-11.
6. Ravindran, R., Lehr, H. A., Xian, M., et al. "Nicotinamide as an Anti-Inflammatory Compound." International Immunology, 2016;28(2):47-58.
7. Trammell, S. A., Brenner, C. "Rebuilding Mitochondria With Nicotinamide Riboside." Cell Metabolism, 2013;18(1):5-7.
8. Virtanen, J. K., Mursu, J., Voutilainen, S., Tuomainen, T. P. "Serum Vitamin B6 and the Risk of Cognitive Decline in Community-Dwelling Older Adults." Journal of the American Geriatrics Society, 2016;64(9):1800-1806.
9. Werneke, U., Turner, T., Priebe, S. "Complementary Medicines in Psychiatry: Review of Effectiveness and Safety." British Journal of Psychiatry, 2006;188:109-121.
10. Ziegler, O., Quilliot, D., Burkle, A., Cattan, P. "NAD+ Replenishment as a Therapeutic Strategy." Journal of Gerontology Series A: Biological Sciences and Medical Sciences, 2015;70(6):715-723.

Disclaimer

This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not constitute medical advice and is independent of any specific product or brand. Always consult a qualified healthcare provider before beginning any new supplement regimen, particularly if you are pregnant, breastfeeding, taking medications, or managing a medical condition.